9-114426193-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015404.4(WHRN):​c.1166+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00572 in 1,611,748 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0043 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0059 ( 35 hom. )

Consequence

WHRN
NM_015404.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.72

Publications

2 publications found
Variant links:
Genes affected
WHRN (HGNC:16361): (whirlin) This gene is thought to function in the organization and stabilization of sterocilia elongation and actin cystoskeletal assembly, based on studies of the related mouse gene. Mutations in this gene have been associated with autosomal recessive non-syndromic deafness and Usher Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
WHRN Gene-Disease associations (from GenCC):
  • Usher syndrome type 2D
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • autosomal recessive nonsyndromic hearing loss 31
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 9-114426193-C-T is Benign according to our data. Variant chr9-114426193-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137079.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00432 (658/152232) while in subpopulation NFE AF = 0.00731 (497/68008). AF 95% confidence interval is 0.00678. There are 2 homozygotes in GnomAd4. There are 287 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WHRNNM_015404.4 linkc.1166+18G>A intron_variant Intron 4 of 11 ENST00000362057.4 NP_056219.3 Q9P202-1B9EGE6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WHRNENST00000362057.4 linkc.1166+18G>A intron_variant Intron 4 of 11 1 NM_015404.4 ENSP00000354623.3 Q9P202-1

Frequencies

GnomAD3 genomes
AF:
0.00433
AC:
658
AN:
152114
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00575
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00731
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00467
AC:
1171
AN:
250518
AF XY:
0.00478
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.00983
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00735
Gnomad NFE exome
AF:
0.00665
Gnomad OTH exome
AF:
0.00473
GnomAD4 exome
AF:
0.00587
AC:
8565
AN:
1459516
Hom.:
35
Cov.:
30
AF XY:
0.00589
AC XY:
4274
AN XY:
726044
show subpopulations
African (AFR)
AF:
0.000628
AC:
21
AN:
33414
American (AMR)
AF:
0.00134
AC:
60
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0111
AC:
290
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00260
AC:
224
AN:
86166
European-Finnish (FIN)
AF:
0.00717
AC:
381
AN:
53116
Middle Eastern (MID)
AF:
0.000964
AC:
4
AN:
4150
European-Non Finnish (NFE)
AF:
0.00652
AC:
7255
AN:
1111902
Other (OTH)
AF:
0.00545
AC:
328
AN:
60210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
493
985
1478
1970
2463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00432
AC:
658
AN:
152232
Hom.:
2
Cov.:
33
AF XY:
0.00386
AC XY:
287
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00104
AC:
43
AN:
41544
American (AMR)
AF:
0.000850
AC:
13
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4820
European-Finnish (FIN)
AF:
0.00575
AC:
61
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00731
AC:
497
AN:
68008
Other (OTH)
AF:
0.00237
AC:
5
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00584
Hom.:
1
Bravo
AF:
0.00377
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 19, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 08, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2D;C1846839:Autosomal recessive nonsyndromic hearing loss 31 Benign:1
Jan 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.0030
DANN
Benign
0.61
PhyloP100
-4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149202009; hg19: chr9-117188473; API